Relugolix

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 224 publications

New perspectives in managing chronic pelvic pain in Endometriosis: the role of GnRH antagonists versus dienogest.

New perspectives in managing chronic pelvic pain in Endometriosis: the role of GnRH antagonists versus dienogest.

Journal: Expert opinion on pharmacotherapy

Published: April 10, 2026

Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.

Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.

Journal: Urology practice

Published: February 23, 2026

Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer.

Journal: Cureus

Published: February 22, 2026

Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial.

Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial.

Journal: JAMA cardiology

Published: February 18, 2026

Sexual function in perimenopausal women treated with relugolix and add back therapy for uterine fibroids: an observational study.

Sexual function in perimenopausal women treated with relugolix and add back therapy for uterine fibroids: an observational study.

Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Published: January 14, 2026

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: December 18, 2025

Clinical Effectiveness of Oral Relugolix in Advanced Prostate Cancer: A Structured Review of Current Primary Research.

Clinical Effectiveness of Oral Relugolix in Advanced Prostate Cancer: A Structured Review of Current Primary Research.

Journal: Cureus

Published: November 19, 2025

Oral relugolix for the treatment of advanced prostate cancer.

Oral relugolix for the treatment of advanced prostate cancer.

Journal: The oncologist

Published: November 14, 2025

Unexpected Fatal Pneumocystis Jirovecii Pneumonia During Triplet Therapy for Hormone-Sensitive Prostate Cancer.

Unexpected Fatal Pneumocystis Jirovecii Pneumonia During Triplet Therapy for Hormone-Sensitive Prostate Cancer.

Journal: Respirology case reports

Published: October 31, 2025

The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy: a randomized controlled noninferiority study (MyLacR study).

The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy: a randomized controlled noninferiority study (MyLacR study).

Journal: Fertility and sterility

Published: October 09, 2025

Results of relugolix/estradiol/norethisterone acetate combination therapy in real-world clinical practice: Effectiveness, tolerability, and factors influencing discontinuation.

Results of relugolix/estradiol/norethisterone acetate combination therapy in real-world clinical practice: Effectiveness, tolerability, and factors influencing discontinuation.

Journal: European journal of obstetrics & gynecology and reproductive biology: X

Published: October 07, 2025

Efficacy and safety of relugolix therapy for symptomatic uterine fibroids: a systematic review and meta-analysis.

Efficacy and safety of relugolix therapy for symptomatic uterine fibroids: a systematic review and meta-analysis.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: October 07, 2025

Showing 1-12 of 224

Last Updated: 04/28/2026